ABS — Arctic Bioscience AS Balance Sheet
0.000.00%
- NOK83.26m
- NOK126.30m
- NOK43.48m
Annual balance sheet for Arctic Bioscience AS, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | NAS | NAS | NAS | NAS | NAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14.2 | 231 | 149 | 90.8 | 14.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11 | 7.7 | 13.5 | 9.57 | 14.6 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 52.6 | 267 | 198 | 133 | 57.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.36 | 16 | 22.3 | 26.4 | 24.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 93.2 | 341 | 328 | 300 | 280 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.7 | 20.9 | 40.4 | 39.6 | 67.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 29.3 | 20.9 | 40.4 | 41.7 | 69 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Other Equity | |||||
| Total Equity | 63.9 | 321 | 287 | 259 | 211 |
| Total Liabilities & Shareholders' Equity | 93.2 | 341 | 328 | 300 | 280 |
| Total Common Shares Outstanding |